MRX
Marex Group Plc
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
Marex Group Plc
Current Price
$56.22
-1.99%GoodMoat Value
$149.05
165.1% undervaluedProfile
Valuation (TTM)
Market Cap$4.10B
P/E13356822.68
EV—
P/B3.52
Shares Out72.94M
P/Sales2471696.54
Revenue$1659.00
EV/EBITDA—
Marex Group Plc (MRX) Stock Analysis
Market Cap$4.10B
Current Price$56.22
P/E Ratio13356822.68
Forward P/E—
PEG Ratio—
EPS$3.86
Book Value$15.99
P/B Ratio3.52
MRX Financial Charts
FCF vs CAPEX
FCFCAPEX
Forward estimates use 7.8% FCF growth (CAGR)
Cash vs Debt
Net Debt: 15.0B
Revenue
542M
FY21
711M
FY22
1.2B
FY23
1.2B
FY24
2.0B
FY25
Net Income
57M
FY21
92M
FY22
128M
FY23
128M
FY24
294M
FY25
MRX 52-Week Range
$27.99
$58.25
50-Day MA: $46.69200-Day MA: $38.55
Did you know?
Net income compounded at 51.1% annually over 4 years.
Marex Group Plc (MRX) Financial Summary
Marex Group Plc (MRX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ. The stock currently trades at $56.22 with a market capitalization of $4.10B.
Key valuation metrics include a P/E ratio of 13356822.68, price-to-book ratio of 3.52, and EPS of $3.86. The company reports a profit margin of 15.3% and return on equity of 0.0%.
MRX Key Financial Metrics
| Metric | Value |
|---|---|
| Market Cap | $4.10B |
| P/E Ratio | 13356822.68 |
| EPS | $3.86 |
| P/B Ratio | 3.52 |
| P/S Ratio | 2471696.54 |
| Dividend Yield | 1.35% |
| Profit Margin | 15.3% |
| Return on Equity | 0.0% |
| Debt/Equity | 15.33 |
MRX Revenue & Earnings History
| Year | Revenue | Net Income |
|---|---|---|
| FY21 | $541.50M | $56.50M |
| FY22 | $711.10M | $91.60M |
| FY23 | $1.24B | $128.00M |
| FY24 | $1.24B | $128.00M |
| FY25 | $2.02B | $294.40M |
Marex Group Plc (MRX) Valuation
Based on GoodMoat's DCF model, Marex Group Plc has a fair value estimate of $149.05. At the current price of $56.22, the stock appears 62.3% undervalued relative to our intrinsic value estimate.
MRX Quality Indicators
Marex Group Plc maintains a profit margin of 15.3% and an operating margin of 19.8%. Return on equity stands at 0.0%. The current ratio is 1.09. Debt-to-equity ratio is 15.33.
About Marex Group Plc
Marex Group Plc
MRX Free Cash Flow
Marex Group Plc generated $654.40M in trailing twelve-month free cash flow, representing an FCF yield of 15.96%. This strong FCF yield suggests the company generates substantial cash relative to its market value.
MRX Shares Outstanding
Marex Group Plc has 0.07 billion shares outstanding at a share price of $56.22, giving it a market capitalization of $4.10B.